These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1044 related articles for article (PubMed ID: 33524124)

  • 1. Dysregulated Innate and Adaptive Immune Responses Discriminate Disease Severity in COVID-19.
    Janssen NAF; Grondman I; de Nooijer AH; Boahen CK; Koeken VACM; Matzaraki V; Kumar V; He X; Kox M; Koenen HJPM; Smeets RL; Joosten I; Brüggemann RJM; Kouijzer IJE; van der Hoeven HG; Schouten JA; Frenzel T; Reijers MHE; Hoefsloot W; Dofferhoff ASM; van Apeldoorn MJ; Blaauw MJT; Veerman K; Maas C; Schoneveld AH; Hoefer IE; Derde LPG; van Deuren M; van der Meer JWM; van Crevel R; Giamarellos-Bourboulis EJ; Joosten LAB; van den Heuvel MM; Hoogerwerf J; de Mast Q; Pickkers P; Netea MG; van de Veerdonk FL
    J Infect Dis; 2021 Apr; 223(8):1322-1333. PubMed ID: 33524124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome.
    Azar MM; Shin JJ; Kang I; Landry M
    Expert Rev Mol Diagn; 2020 Nov; 20(11):1087-1097. PubMed ID: 32990479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Longitudinal Immune Response to Coronavirus Disease 2019: Chasing the Cytokine Storm.
    Chau AS; Weber AG; Maria NI; Narain S; Liu A; Hajizadeh N; Malhotra P; Bloom O; Marder G; Kaplan B
    Arthritis Rheumatol; 2021 Jan; 73(1):23-35. PubMed ID: 32929876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe immunosuppression and not a cytokine storm characterizes COVID-19 infections.
    Remy KE; Mazer M; Striker DA; Ellebedy AH; Walton AH; Unsinger J; Blood TM; Mudd PA; Yi DJ; Mannion DA; Osborne DF; Martin RS; Anand NJ; Bosanquet JP; Blood J; Drewry AM; Caldwell CC; Turnbull IR; Brakenridge SC; Moldwawer LL; Hotchkiss RS
    JCI Insight; 2020 Sep; 5(17):. PubMed ID: 32687484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine release syndrome in COVID-19: Innate immune, vascular, and platelet pathogenic factors differ in severity of disease and sex.
    Petrey AC; Qeadan F; Middleton EA; Pinchuk IV; Campbell RA; Beswick EJ
    J Leukoc Biol; 2021 Jan; 109(1):55-66. PubMed ID: 32930456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine Elevation in Severe COVID-19 From Longitudinal Proteomics Analysis: Comparison With Sepsis.
    Ebihara T; Matsumoto H; Matsubara T; Togami Y; Nakao S; Matsuura H; Kojima T; Sugihara F; Okuzaki D; Hirata H; Yamamura H; Ogura H
    Front Immunol; 2021; 12():798338. PubMed ID: 35095877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immune response to SARS-CoV-2 and COVID-19 immunopathology - Current perspectives.
    Boechat JL; Chora I; Morais A; Delgado L
    Pulmonology; 2021; 27(5):423-437. PubMed ID: 33867315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune profiling of COVID-19: preliminary findings and implications for the pandemic.
    Maecker HT
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 33963016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperinflammation and Immune Response Generation in COVID-19.
    Mishra KP; Singh AK; Singh SB
    Neuroimmunomodulation; 2020; 27(2):80-86. PubMed ID: 33341814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine profiling in Iranian patients with COVID-19; association with clinical severity.
    Taghiloo S; Soltanshahi M; Aliyali M; Abedi S; Mehravaran H; Ajami A; Asgarian-Omran H
    Iran J Immunol; 2021 Mar; 18(1):54-64. PubMed ID: 33787514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune dysregulation and system pathology in COVID-19.
    Jamal M; Bangash HI; Habiba M; Lei Y; Xie T; Sun J; Wei Z; Hong Z; Shao L; Zhang Q
    Virulence; 2021 Dec; 12(1):918-936. PubMed ID: 33757410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperinflammatory Immune Response and COVID-19: A Double Edged Sword.
    Tan LY; Komarasamy TV; Rmt Balasubramaniam V
    Front Immunol; 2021; 12():742941. PubMed ID: 34659238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial dysfunction contributes to severe COVID-19 in combination with dysregulated lymphocyte responses and cytokine networks.
    Ruhl L; Pink I; Kühne JF; Beushausen K; Keil J; Christoph S; Sauer A; Boblitz L; Schmidt J; David S; Jäck HM; Roth E; Cornberg M; Schulz TF; Welte T; Höper MM; Falk CS
    Signal Transduct Target Ther; 2021 Dec; 6(1):418. PubMed ID: 34893580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical COVID-19 is associated with distinct leukocyte phenotypes and transcriptome patterns.
    Christensen EE; Jørgensen MJ; Nore KG; Dahl TB; Yang K; Ranheim T; Huse C; Lind A; Nur S; Stiksrud B; Jenum S; Tonby K; Holter JC; Holten AR; Halvorsen B; Dyrhol-Riise AM
    J Intern Med; 2021 Sep; 290(3):677-692. PubMed ID: 34080738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profiling of immune dysfunction in COVID-19 patients allows early prediction of disease progression.
    Rendeiro AF; Casano J; Vorkas CK; Singh H; Morales A; DeSimone RA; Ellsworth GB; Soave R; Kapadia SN; Saito K; Brown CD; Hsu J; Kyriakides C; Chiu S; Cappelli LV; Cacciapuoti MT; Tam W; Galluzzi L; Simonson PD; Elemento O; Salvatore M; Inghirami G
    Life Sci Alliance; 2021 Feb; 4(2):. PubMed ID: 33361110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Impaired Inflammatory and Innate Immune Response in COVID-19.
    Park SH
    Mol Cells; 2021 Jun; 44(6):384-391. PubMed ID: 34098591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 Severity Is Associated with Differential Antibody Fc-Mediated Innate Immune Functions.
    Adeniji OS; Giron LB; Purwar M; Zilberstein NF; Kulkarni AJ; Shaikh MW; Balk RA; Moy JN; Forsyth CB; Liu Q; Dweep H; Kossenkov A; Weiner DB; Keshavarzian A; Landay A; Abdel-Mohsen M
    mBio; 2021 Apr; 12(2):. PubMed ID: 33879594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 multifaceted interaction with the human host. Part II: Innate immunity response, immunopathology, and epigenetics.
    Beacon TH; Su RC; Lakowski TM; Delcuve GP; Davie JR
    IUBMB Life; 2020 Nov; 72(11):2331-2354. PubMed ID: 32936531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-related differences in the immune response could contribute to determine the spectrum of severity of COVID-19.
    Costagliola G; Spada E; Consolini R
    Immun Inflamm Dis; 2021 Jun; 9(2):331-339. PubMed ID: 33566457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The COVID-19 immune landscape is dynamically and reversibly correlated with disease severity.
    Bolouri H; Speake C; Skibinski D; Long SA; Hocking AM; Campbell DJ; Hamerman JA; Malhotra U; Buckner JH;
    J Clin Invest; 2021 Feb; 131(3):. PubMed ID: 33529167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.